IRIS
FLAMMINI, Lisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.241
AS - Asia 3.316
EU - Europa 2.711
SA - Sud America 370
AF - Africa 209
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 11.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.111
SG - Singapore 1.096
CN - Cina 937
IT - Italia 628
VN - Vietnam 534
FI - Finlandia 422
SE - Svezia 384
IE - Irlanda 382
BR - Brasile 277
DE - Germania 249
HK - Hong Kong 228
BD - Bangladesh 142
ZA - Sudafrica 130
FR - Francia 126
UA - Ucraina 117
NL - Olanda 115
TR - Turchia 97
GB - Regno Unito 82
IN - India 80
CA - Canada 78
RU - Federazione Russa 51
CI - Costa d'Avorio 39
AR - Argentina 35
BE - Belgio 33
ES - Italia 25
MX - Messico 25
JP - Giappone 24
PL - Polonia 24
KR - Corea 21
ID - Indonesia 20
PK - Pakistan 18
CZ - Repubblica Ceca 17
IQ - Iraq 16
PH - Filippine 14
AT - Austria 13
EC - Ecuador 13
CO - Colombia 11
TW - Taiwan 10
PY - Paraguay 9
RO - Romania 9
TH - Thailandia 9
UZ - Uzbekistan 8
VE - Venezuela 8
CH - Svizzera 7
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
MY - Malesia 7
NP - Nepal 7
SA - Arabia Saudita 7
BO - Bolivia 6
CR - Costa Rica 6
PA - Panama 6
AZ - Azerbaigian 5
EU - Europa 5
MA - Marocco 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
ET - Etiopia 4
IR - Iran 4
AL - Albania 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KZ - Kazakistan 3
LT - Lituania 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
SC - Seychelles 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
CL - Cile 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MC - Monaco 1
Totale 11.847
Salva come PNG Salva come JPEG
Città #
Dallas 1.566
Singapore 617
Ashburn 504
Chandler 398
Dublin 381
San Jose 339
Santa Clara 246
Beijing 233
Ann Arbor 222
Parma 213
Hong Kong 210
Ho Chi Minh City 164
Dearborn 149
Jacksonville 147
Boardman 128
Johannesburg 127
New York 115
Hanoi 108
Shanghai 85
Munich 84
Los Angeles 82
Nanjing 78
Izmir 74
Princeton 60
Lauterbourg 58
Hefei 52
Milan 47
Chicago 40
Wilmington 40
Abidjan 39
Council Bluffs 39
Helsinki 38
Buffalo 36
Bremen 35
Toronto 34
Groningen 33
Brussels 30
San Mateo 29
Bangalore 27
Kunming 26
Des Moines 25
São Paulo 25
Bologna 23
Guangzhou 23
Moscow 23
Columbus 22
Haiphong 22
Hebei 22
Jinan 22
Da Nang 21
Montreal 20
Shenyang 20
Tokyo 20
Nanchang 19
Houston 18
London 18
Marseille 18
Rome 18
Seattle 18
Changsha 17
Frankfurt am Main 17
Fremont 16
The Dalles 16
Turku 16
Warsaw 16
Stockholm 15
Tianjin 15
Denver 13
Jakarta 13
Norwalk 13
Redmond 13
Reggio Emilia 13
Brno 12
Jiaxing 12
Manchester 12
Mexico City 12
Nuremberg 12
Brooklyn 11
Ottawa 11
Rio de Janeiro 11
Seoul 11
Atlanta 10
Chennai 10
Modena 10
Amsterdam 9
Boston 9
Can Tho 9
Hangzhou 9
Montegaldella 9
Naples 9
Poplar 9
Grafing 8
Orem 8
Vienna 8
Woodbridge 8
Zhengzhou 8
Amman 7
Ankara 7
Curitiba 7
Dhaka 7
Totale 7.788
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.702
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 253
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 247
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 246
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 231
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 229
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 220
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 216
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 209
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 202
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 198
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 193
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 190
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 189
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 179
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 177
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 177
Antitumoral effect of a nanotechnology-based photodynamic therapy. 177
Hake fish bone as a calcium source for efficient bone mineralization 175
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 169
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 167
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 167
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 166
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 166
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 165
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 162
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 162
Analgesic activity of new hybrid muscarinic agonists in mice 161
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 159
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 155
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary study 153
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 152
Brain Pharmacokinetics of Non-Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray-Mass Spectrometry and ex vivo Binding Study in Rats 151
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 150
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 147
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 145
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 142
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 142
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 141
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 141
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 137
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 134
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 129
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 129
Lithocholic acid competitively inhibitis EphA2-ephrinA1 binding: pharmacological and structural considerations. 127
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 127
Lithocholic acid competitively inhibits EphA2-ephrinA1 binding: pharmacological and structural considerations. 125
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. 123
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 123
Effects of CCL20/CCR6 modulators in a T cell adoptive transfer model of colitis 120
α7 Nicotinic Agonist AR-R17779 Protects Mice against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in a Spleen-Dependent Way 119
Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions 118
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 112
Analgesic effects mediated by muscarinic ligands acting at both orthosteric and allosteric receptor binding sites 111
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 109
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 109
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 108
EphA2-ephrinA1 system in acute mesenteric inflammation due to ischemia-reperfusion in mice 108
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease 105
Synthesis and characterization of new bivalent agents as melatonin- and histamine h3-ligands. 105
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 105
Novel potent N-Methyl-d-Aspartate (NMDA) receptor antagonists or s1 receptor ligands based on properly substituted 1,4-dioxane ring 102
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 98
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors 95
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 90
New selective PDE4D inhibitors devoid of sedative effects in mice 89
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors 85
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 84
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice 84
Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2 73
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases 14
Totale 11.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022391 21 16 25 48 24 17 32 32 18 27 13 118
2022/20231.393 168 170 84 106 129 154 30 63 407 14 53 15
2023/2024656 23 54 12 29 43 143 67 36 24 37 70 118
2024/20251.765 84 87 114 124 188 196 74 68 188 152 161 329
2025/20265.627 417 624 1.510 418 598 234 415 161 536 306 269 139
2026/202754 54 0 0 0 0 0 0 0 0 0 0 0
Totale 11.970